Insider Selling: Werewolf Therapeutics (NASDAQ:HOWL) Director Sells 38,782 Shares of Stock
Werewolf Therapeutics, Inc. (NASDAQ:HOWL – Get Free Report) Director Luke Evnin sold 38,782 shares of the stock in a transaction dated Friday, January 16th. The stock was sold at an average price of $0.54, for a total transaction of $20,942.28. Following the completion of the transaction, the director directly owned 2,159,860 shares of the company’s […]
20 Jan 21:48 · The Markets Daily